The Nbeal2^−/− mouse as a model for the gray platelet syndrome

References

• Gunay-Aygun M, Zivony-Elboum Y, Gumruk F, Geiger D, Cetin M, Khayat M, Kleta R, Kfir N, Anikster Y, Chezar J, et al. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood 2010; 116:4990 - 5001; http://dx.doi.org/10.1182/blood-2010-05-286534; PMID: 20709904
   PubMed Web of Science ®Google Scholar
• Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 2007; 21:21 - 36; http://dx.doi.org/10.1016/j.blre.2005.12.003; PMID: 16442192
   PubMed Web of Science ®Google Scholar
• Stegner D, Nieswandt B. Platelet receptor signaling in thrombus formation. J Mol Med (Berl) 2011; 89:109 - 21; http://dx.doi.org/10.1007/s00109-010-0691-5; PMID: 21058007
   PubMed Web of Science ®Google Scholar
• Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009; 23:177 - 89; http://dx.doi.org/10.1016/j.blre.2009.04.001; PMID: 19450911
   PubMed Web of Science ®Google Scholar
• Jackson SP. Arterial thrombosis--insidious, unpredictable and deadly. Nat Med 2011; 17:1423 - 36; http://dx.doi.org/10.1038/nm.2515; PMID: 22064432
   PubMed Web of Science ®Google Scholar
• Raccuglia G. Gray platelet syndrome. A variety of qualitative platelet disorder. Am J Med 1971; 51:818 - 28; http://dx.doi.org/10.1016/0002-9343(71)90311-1; PMID: 5129551
   PubMed Web of Science ®Google Scholar
• Breton-Gorius J, Vainchenker W, Nurden A, Levy-Toledano S, Caen J. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. Am J Pathol 1981; 102:10 - 9; PMID: 7468753
   PubMed Web of Science ®Google Scholar
• Rosa JP, George JN, Bainton DF, Nurden AT, Caen JP, McEver RP. Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface. J Clin Invest 1987; 80:1138 - 46; http://dx.doi.org/10.1172/JCI113171; PMID: 2443536
   PubMed Web of Science ®Google Scholar
• Albers CA, Cvejic A, Favier R, Bouwmans EE, Alessi M-C, Bertone P, Jordan G, Kettleborough RN, Kiddle G, Kostadima M, et al. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat Genet 2011; 43:735 - 7; http://dx.doi.org/10.1038/ng.885; PMID: 21765411
   PubMed Web of Science ®Google Scholar
• Gunay-Aygun M, Falik-Zaccai TC, Vilboux T, Zivony-Elboum Y, Gumruk F, Cetin M, Khayat M, Boerkoel CF, Kfir N, Huang Y, et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nat Genet 2011; 43:732 - 4; http://dx.doi.org/10.1038/ng.883; PMID: 21765412
   PubMed Web of Science ®Google Scholar
• Kahr WH, Hinckley J, Li L, Schwertz H, Christensen H, Rowley JW, Pluthero FG, Urban D, Fabbro S, Nixon B, et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet 2011; 43:738 - 40; http://dx.doi.org/10.1038/ng.884; PMID: 21765413
   PubMed Web of Science ®Google Scholar
• Wang X, Herberg FW, Laue MM, Wullner C, Hu B, Petrasch-Parwez E, Kilimann MW. Neurobeachin: A protein kinase A-anchoring, beige/Chediak-higashi protein homolog implicated in neuronal membrane traffic. J Neurosci 2000; 20:8551 - 65; PMID: 11102458
   PubMed Web of Science ®Google Scholar
• Deppermann C, Cherpokova D, Nurden P, Schulz JN, Thielmann I, Kraft P, Vögtle T, Kleinschnitz C, Dütting S, Krohne G, et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J Clin Invest 2013; 123:3331 - 42; http://dx.doi.org/10.1172/JCI69210; PMID: 23863626
   PubMed Web of Science ®Google Scholar
• Kahr WH, Lo RW, Li L, Pluthero FG, Christensen H, Ni R, Vaezzadeh N, Hawkins CE, Weyrich AS, Di Paola J, et al. Abnormal megakaryocyte development and platelet function in Nbeal2-/- mice. Blood 2013; http://dx.doi.org/10.1182/blood-2013-04-499491; PMID: 23861251
   PubMed Web of Science ®Google Scholar
• Nurden AT, Nurden P, Bermejo E, Combrié R, McVicar DW, Washington AV. Phenotypic heterogeneity in the Gray platelet syndrome extends to the expression of TREM family member, TLT-1. Thromb Haemost 2008; 100:45 - 51; PMID: 18612537
   PubMed Web of Science ®Google Scholar
• Morowski M, Vögtle T, Kraft P, Kleinschnitz C, Stoll G, Nieswandt B. Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice. Blood 2013; 121:4938 - 47; http://dx.doi.org/10.1182/blood-2012-10-461459; PMID: 23584880
   PubMed Web of Science ®Google Scholar
• Bottega R, Pecci A, De Candia E, Pujol-Moix N, Heller PG, Noris P, De Rocco D, Podda GM, Glembotsky AC, Cattaneo M, et al. Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency. Haematologica 2013; 98:868 - 74; http://dx.doi.org/10.3324/haematol.2012.075861; PMID: 23100277
   PubMed Web of Science ®Google Scholar
• Bertozzi CC, Hess PR, Kahn ML. Platelets: covert regulators of lymphatic development. Arterioscler Thromb Vasc Biol 2010; 30:2368 - 71; http://dx.doi.org/10.1161/ATVBAHA.110.217281; PMID: 21071706
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Stefanini L. Platelet ITAM signaling. Curr Opin Hematol 2013; 20:445 - 50; http://dx.doi.org/10.1097/MOH.0b013e3283642267; PMID: 23921514
   PubMed Web of Science ®Google Scholar
• Goerge T, Ho-Tin-Noe B, Carbo C, Benarafa C, Remold-O’Donnell E, Zhao B-Q, Cifuni SM, Wagner DD. Inflammation induces hemorrhage in thrombocytopenia. Blood 2008; 111:4958 - 64; http://dx.doi.org/10.1182/blood-2007-11-123620; PMID: 18256319
   PubMed Web of Science ®Google Scholar
• Burgess A, Mornon JP, de Saint-Basile G, Callebaut I. A concanavalin A-like lectin domain in the CHS1/LYST protein, shared by members of the BEACH family. Bioinformatics 2009; 25:1219 - 22; http://dx.doi.org/10.1093/bioinformatics/btp151; PMID: 19289442
   PubMed Web of Science ®Google Scholar
• Cullinane AR, Schäffer AA, Huizing M. The BEACH is hot: a LYST of emerging roles for BEACH-domain containing proteins in human disease. Traffic 2013; 14:749 - 66; http://dx.doi.org/10.1111/tra.12069; PMID: 23521701
   PubMed Web of Science ®Google Scholar
• Urban D, Li L, Christensen H, Pluthero FG, Chen SZ, Puhacz M, Garg PM, Lanka KK, Cummings JJ, Kramer H, et al. The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis. Blood 2012; 120:5032 - 40; http://dx.doi.org/10.1182/blood-2012-05-431205; PMID: 23002115
   PubMed Web of Science ®Google Scholar
• Nurden P, Gobbi G, Nurden A, Enouf J, Youlyouz-Marfak I, Carubbi C, La Marca S, Punzo M, Baronciani L, De Marco L, et al. Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B. Blood 2010; 115:2649 - 56; http://dx.doi.org/10.1182/blood-2009-07-231886; PMID: 20118404
   PubMed Web of Science ®Google Scholar